
|Expert Interviews|September 1, 2020
Diana Isaacs, PharmD: An Overview of Insulin Affordability in 2020
The affordability of insulin is a constant topic of discussion for diabetics and their care providers. While the cost of medication was already an issue for many diabetic patients, it has been further compounded by the ongoing pandemic.
Advertisement
In the following interview, Diana Isaacs, PharmD, a clinical pharmacist and diabetes care and education specialist at the Cleveland Clinic, discusses the affordability of insulin and how the ability of patients to afford their medications has been impacted by the pandemic. A leader in her field, Isaacs offers perspective on topics from how to approach these delicate conversations with patients to the best resources for patients who may be struggling to afford their insulin.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
Executive Order Calls for Realignment of Childhood Vaccines
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Heat and Older Adults: What Pharmacists Need to Know
5





























































